Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Price:
29.78 USD
-2.36%
Market Closed
Updated:
May 20, 2024
Arcturus Therapeutics Holdings Inc
Accounts Payable
|
Arcturus Therapeutics Holdings Inc
Accounts Payable Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
|
Accounts Payable
$9.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
17%
|
CAGR 10-Years
21%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Accounts Payable
$31.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
22%
|
CAGR 10-Years
18%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Accounts Payable
$622m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Accounts Payable
$1.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Accounts Payable
$351.4m
|
CAGR 3-Years
40%
|
CAGR 5-Years
34%
|
CAGR 10-Years
22%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Accounts Payable
$671.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
23%
|
CAGR 10-Years
35%
|
See Also
What is Arcturus Therapeutics Holdings Inc's Accounts Payable?
Accounts Payable
9.1m
USD
9.1m
USD
Based on the financial report for Mar 31, 2024, Arcturus Therapeutics Holdings Inc's Accounts Payable amounts to 9.1m USD.
What is Arcturus Therapeutics Holdings Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
21%
21%
Over the last year, the Accounts Payable growth was -53%. The average annual Accounts Payable growth rates for Arcturus Therapeutics Holdings Inc have been 18% over the past three years , 17% over the past five years , and 21% over the past ten years .
You don't have any saved screeners yet
